Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Benqiao Wang
Observed name:
B. Wang
Institutions:
First Hospital of China Medical University,
China Medical University
Observed institutions:
Jinshan Hospital of Fudan University,
First Hospital of China Medical University,
China Medical University
ORCID:
0009-0004-0743-5813
Observed ORCID:
0009-0004-0743-5813
OpenAlex ID:
A5012778926
Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases
2023
·
Ying Zhu
, Benqiao Wang
, et al.
·
Frontiers in Immunology
·
64
PDF
Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities
2024
·
Chi Ma
, Dan Liu
, et al.
·
Frontiers in Pharmacology
·
19
Beyond the Surface: Investigating the Potential Mechanisms of Non‐Motor Symptoms in Myasthenia Gravis
2025
·
Benqiao Wang
, Dan Liu
, et al.
·
European Journal of Neurology
·
11
PDF
The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment
2024
·
Benqiao Wang
, Ying Zhu
, et al.
·
Frontiers in Immunology
·
5
PDF
Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety
2026
·
Chi Ma
, Jingyi Shen
, et al.
·
Current Neuropharmacology
·
3
PDF
Telitacicept as a New Therapeutic Avenue for Generalized Myasthenia Gravis and Thymoma-Associated Myasthenia Gravis
2026
·
Ying Zhu
, Benqiao Wang
, et al.
·
Journal of Neuroimmune Pharmacology
·
3
The MAGI2 gene polymorphism rs2160322 is associated with Graves’ disease but not with Hashimoto’s thyroiditis
2018
·
X. Jia
, T. Zhai
, et al.
·
Journal of Endocrinological Investigation
·
2
Development and Validation of a Nomogram to Predict Minimal Symptom Expression in AChR+ gMG Patients Undergoing Efgartigimod Therapy
2026
·
Chi Ma
, Nan Kang
, et al.
·
Current Neuropharmacology
Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG
2026
·
Tianying Ma
, Yanan Liu
, et al.
·
ImmunoTargets and Therapy
PDF
Show more works
View as search
Works count:
9
Citation count:
107
H-index:
4
I10-index:
3
Year
Topic
Type